MCM
TAK icon

MV Capital Management’s Takeda Pharmaceutical TAK Stock Holding History

MV Capital Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.37K Buy
182
+154
+550% +$2.7K ﹤0.01% 680
2025
Q4 		$437 Buy
+28
New +$400 ﹤0.01% 935

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MV Capital Management's TAK Position: Q1 2026 in Review

MV Capital Management increased its Takeda Pharmaceutical (TAK) stake by 550% in Q1 2026, buying an estimated $2.7K and bringing the position to 182 shares worth $3.37K. The position accounts for ﹤0.01% of the portfolio, ranked #680.

MV Capital Management first reported a position in TAK in Q4 2025 and has held it in 2 quarters since. 358 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

  • MV Capital Management held 182 shares of Takeda Pharmaceutical worth $3.37K as of Q1 2026.
  • MV Capital Management bought 154 Takeda Pharmaceutical shares in Q1 2026, an estimated $2.7K.
  • Takeda Pharmaceutical made up ﹤0.01% of MV Capital Management's portfolio in Q1 2026, its #680 holding.
  • MV Capital Management first reported a position in Takeda Pharmaceutical in Q4 2025 and has held it in 2 quarters since.
  • 358 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on MV Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.